Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase 3 1

Status

Unknown 3Withdrawn 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 10Breast 4Tumor-Agnostic 3Thoracic 2Genitourinary 2Plasma cell 1Head & Neck 1

Conditions

Neoplasms 2Carcinoma, Squamous Cell 1

Interventions

Radiotherapy 9Drug Therapy 9Cisplatin 9Gemcitabine 8Docetaxel 7Carboplatin 7Blood Specimen Collection 7Nivolumab 6Fluorouracil 6Pemetrexed 5Capecitabine 5pembrolizumab 4Surveys and Questionnaires 4Positron Emission Tomography Computed Tomography 4Paclitaxel 4Oxaliplatin 4Exercise 4Everolimus 4Data Collection 4Cetuximab 4indibulin 3icotinib 3Vincristine 3Trastuzumab 3Standard of Care 3Radiosurgery 3Neoadjuvant Therapy 3Magnetic Resonance Spectroscopy 3Interleukin-2 3Injections 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × Aspirin × Tumor-Agnostic × Clear all
NCT01968798 2021-04-05

ACES

Hennepin Healthcare Research Institute

Phase 4 Unknown
14,500 enrolled
Tumor-Agnostic

Neoplasms

NCT04256525 2020-06-30

Prophylactic Anticoagulation for Catheter-related Thrombosis

Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase 4 Unknown
1,640 enrolled
Tumor-Agnostic

Neoplasms

NCT01496521 2011-12-21

CREAT

Beijing Friendship Hospital

Phase 3 Unknown
600 enrolled
Tumor-Agnostic

Carcinoma, Squamous Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡